MPE AGM 2019 photo gallery Published March 20, 2019 « ‹ 1 of 6 › » Recent news» Daratumumab becomes the first FDA-approved treatment for patients with newly diagnosed light chain (AL) amyloidosis» Watch the webinar on ASH 2020 myeloma and AL amyloidosis highlights
